← Back to Patent Explorer
US4762839A Expired / Lapsed US ⏱️ 0.0 years remaining

Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications

Assignee: Tanabe Pharma Corp
•
Filing: 1986-05-22
•
Granted: 1988-08-09
•
Expires: 2006-05-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel quinazolinone compounds of the formula: <IMAGE> (I) wherein R is hydrogen atom or a lower alkyl, R1 is a lower alkyl, a substituted or unsubstituted phenyl or an aralkyl, and R2, R3, R4 and R5 are the same or different and are each hydrogen atom, a halogen atom, a lower alkyl, a lower alkoxy, a lower alkoxycarbonyl or a lower alkoxycarbonyl-lower alkenyl, or two adjacent groups of R2,R3, R4 and R5 when taken together form methylenedioxy and the other two are hydrogen atom, and a salt thereof, which are useful for the prophylaxis and treatment of various diabetic complications, and processes for the preparation thereof, and a pharmaceutical composition containing said compound as an active ingredient.

Inventors

  • 👤 Yoshihisa Yamada
  • 👤 Yuzo Matsuoka
  • 👤 Mamoru Matsumoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 06:28
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/10; C07D239/00; C07D239/70; C07D239/72; C07D239/95; C07D239/96

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 57 words
A quinazolinone compound of the formula: ##STR22## wherein R is hydrogen atom or lower alkyl, R 1 is a lower alkyl, and R 2 , R 3 , R 4 and R 5 are the same or different and are each hydrogen atom, a halogen atom, a lower alkyl or a lower alkoxy, or a salt thereof.
Claim 2
Dependent Claim 57 words
A quinazolinone compound of the formula: ##STR22## wherein R is hydrogen atom or lower alkyl, R 1 is a lower alkyl, and R 2 , R 3 , R 4 and R 5 are the same or different and are each hydrogen atom, a halogen atom, a lower alkyl or a lower alkoxy, or a salt thereof.
Claim 3
Dependent Claim 47 words
The compound as claimed in claim 1, wherein R is hydrogen of C 1-4 alkyl; R 1 is C 1-4 alkyl; and R 2 , R 3 , R 4 and R 5 are the same or different and are each hydrogen, halogen or C 1-4 alkyl.
Claim 4
Dependent Claim 45 words
The compound as claimed in claim 1, wherein R is hydrogen or C 1-4 alkyl; R 1 is C 1-4 alkyl; R 2 is hydrogen; R 3 is halogen; R 4 is hydrogen, halogen of C 1-4 alkyl; and R 5 is hydrogen or halogen.
Claim 5
Dependent Claim 42 words
The compound as claimed in claim 3, wherein R is hydrogen or isobutyl; R 1 is methyl; R 2 is hydrogen; R 3 is fluorine, chlorine or bromine; R 4 is hydrogen, chlorine or methyl; and R 5 is hydrogen of chlorine.
Claim 6
Dependent Claim 14 words
The compound as claimed, in claim 4, which is 6-chloro-3-methyl-spiro-[1,2,3,4-tetrahydroquinazoline-4,4'-imidaxolidine]-2,2',5'-trione or a salt thereof.
Claim 7
Dependent Claim 14 words
The compound as claimed in claim 4, which is d-6-chloro-3-methyl-spiro-[1,2,3,4-tetrahydroquinazoline-4,4'-imidazolidine]-2,2',5'-trione or a salt thereof.
Claim 8
Dependent Claim 13 words
An optically active isomer of the compound as set forth in claim 1.
Claim 9
Dependent Claim 12 words
The compound as claimed in claim 7, which is a dextro-rotatory isomer.
Claim 10
Dependent Claim 27 words
A pharmaceutical composition which comprises an effective amount of the compound as set forth in claim 1 in admixture with a conventional pharmaceutically acceptable carrier or diluent.
Claim 11
Dependent Claim 30 words
A method for treatment of diabetic complications in a warm-blooded animal which comprises administering to said warm-blooded animal an effective amount of the compound as set forth in claim 1.

References Cited (Backward Citations)

JPS53653A Cited
US4117230A Cited
US4282229A Cited
JPS5495582A Cited
US4273775A Cited
JPS56104876A Cited
US4248882A Cited
JPS5745185A Cited
US4533667A Cited
US4575507A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-08-09 1992-02-08 1992-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-08-09 1996-02-08 1996-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-08-09 2000-02-08 2000-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag